These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6173327)

  • 1. Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice.
    Weck PK; Rinderknecht E; Estell DA; Stebbing N
    Infect Immun; 1982 Feb; 35(2):660-5. PubMed ID: 6173327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effects of bacteria-derived human leukocyte interferons against encephalomyocarditis virus infection of squirrel monkeys. Brief report.
    Stebbing N; Weck PK; Fenno JT; Estell DA; Rinderknecht E
    Arch Virol; 1983; 76(4):365-72. PubMed ID: 6312932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activities of cloned human leukocyte interferons against herpes simplex virus type 2 infections of mice.
    Fish EN; Banerjee K; Stebbing N
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2317-21. PubMed ID: 6684674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interferons and poly(I):poly(C) on the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in different mouse strains.
    Giron DJ; Agostini HJ; Thomas DC
    J Interferon Res; 1988 Dec; 8(6):745-53. PubMed ID: 2466089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activities of hybrids of two major human leukocyte interferons.
    Weck PK; Apperson S; Stebbing N; Gray PW; Leung D; Shepard HM; Goeddel DV
    Nucleic Acids Res; 1981 Nov; 9(22):6153-66. PubMed ID: 6171779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.
    Sim IS; Cerruti RL
    Antiviral Res; 1987 Nov; 8(4):209-21. PubMed ID: 3128162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells.
    Fish EN; Banerjee K; Stebbing N
    Biochem Biophys Res Commun; 1983 Apr; 112(2):537-46. PubMed ID: 6303322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of interferon action. Kinetics of induction of the antiviral state and protein phosphorylation in mouse fibroblasts treated with natural and cloned interferons.
    Samuel CE; Knutson GS
    J Biol Chem; 1982 Oct; 257(19):11791-5. PubMed ID: 6181059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunicamycin treatment inhibits the antiviral activity of interferon in mice.
    Maheshwari RK; Husain MM; Attallah AM; Friedman RM
    Infect Immun; 1983 Jul; 41(1):61-6. PubMed ID: 6190759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC).
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons protect mice against enterovirus 71 infection.
    Liu ML; Lee YP; Wang YF; Lei HY; Liu CC; Wang SM; Su IJ; Wang JR; Yeh TM; Chen SH; Yu CK
    J Gen Virol; 2005 Dec; 86(Pt 12):3263-3269. PubMed ID: 16298971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effects of human fibroblast interferon from Escherichia coli against encephalomyocarditis virus infection of squirrel monkeys.
    Weck PK; Harkins RN; Stebbing N
    J Gen Virol; 1983 Feb; 64 (Pt 2)():415-9. PubMed ID: 6300291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures.
    Weck PK; Apperson S; May L; Stebbing N
    J Gen Virol; 1981 Nov; 57(Pt 1):233-7. PubMed ID: 6172550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral and antitumor effects of a human interferon analog, IFN-alpha Con 1, assessed in hamsters.
    Altrock BW; Fagin KD; Hockman HR; Fish EN; Goldstein L; Chang D; Duker K; Stebbing N
    J Interferon Res; 1986 Aug; 6(4):405-15. PubMed ID: 3021874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of encephalomyocarditis virus-induced diabetes in mice by antiviral agents.
    Powers RD; Dotson WM; Hayden FG
    Antiviral Res; 1983 Sep; 3(3):151-9. PubMed ID: 6197026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids.
    Sen GC; Herz R; Davatelis V; Pestka S
    J Virol; 1984 May; 50(2):445-50. PubMed ID: 6200607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxyterminal region of hybrid leukocyte interferons affects antiviral specificity.
    Franke AE; Shepard HM; Houck CM; Leung DW; Goeddel DV; Lawn RM
    DNA; 1982; 1(3):223-30. PubMed ID: 6301784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for macrophages for interferon to be effective against encephalomyocarditis virus infection of mice.
    Stebbing N; Dawson KM; Lindley IJ
    Infect Immun; 1978 Jan; 19(1):5-11. PubMed ID: 203537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection.
    Pouillart PR; Audibert FM; Chedid LA; Lefrancier PL; Bahr GM
    Int J Immunopharmacol; 1996 Mar; 18(3):183-92. PubMed ID: 8796446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    Goldberg M; Belkowski LS; Bloom BR
    J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.